In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.
Witter FR, Zimmerman AW, Reichmann JP, Connors SL. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2009 Dec; 201(6):553-9.